CYP2C19 polymorphism and risk for essential tremor

被引：0
|
作者：
Alonso-Navarro, H.
Martinez, C.
Garcia-Martin, E.
Benito-Leon, J.
Garcia-Ferrer, I.
Vazquez-Torres, P.
Puertas, I.
Lopez-Alburquerqe, T.
Agundez, J. A. G.
Jimenez-Jimenez, F. J.
机构：
[1] Univ Alcala de Henares, Hosp Principe Asturias, Madrid, Spain
[2] Univ Extremadura, Dept Pharmacol & Psychiat, Badajoz, Spain
[3] Univ Extremadura, Dept Biochem & Mol Biol, Badajoz, Spain
[4] Hosp Mostoles, Neurol Sect, Mostoles, Spain
[5] Univ Hosp Salamanca, Neurol Sect, Salamanca, Spain
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2006年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [31] CYP2C19 Polymorphism in Korean patients on warfarin therapy
    Sukhyang Lee
    Hyun Jin Hwang
    Jae-Moon Kim
    Chin-Sang Chung
    Jeong Hee Kim
    Archives of Pharmacal Research, 2007, 30
  • [32] CYP2C19*2 and CYP2C19*3 allelomorphism in Turkish population
    Dogan, Ali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 12 - 12
  • [33] CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline
    Laine, K
    Anttila, M
    Nyman, L
    Wahlberg, A
    Bertilsson, L
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (02) : 137 - 142
  • [34] Pharmacokinetics of citalopram in relation to genetic polymorphism of CYP2C19
    Yu, BN
    Chen, GL
    He, N
    Ouyang, DS
    Chen, XP
    Liu, ZQ
    Zhou, HH
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (10) : 1255 - 1259
  • [35] Rabeprazole experience in Korea;: focus on CYP2C19 polymorphism
    Park, SH
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 : S20 - S21
  • [36] Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19
    Wang, JH
    Liu, ZQ
    Wang, W
    Chen, XP
    Shu, Y
    He, N
    Zhou, HH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (01) : 42 - 47
  • [37] CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline
    Kari Laine
    Markku Anttila
    Leena Nyman
    Anneli Wahlberg
    Leif Bertilsson
    European Journal of Clinical Pharmacology, 2001, 57 : 137 - 142
  • [38] A brainstem structural intermediate phenotype of CYP2C19 polymorphism
    Stingl, J. C.
    Paul, A.
    Steffens, M.
    Beschoner, P.
    Bosch, J.
    Dommes, L.
    Viviani, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S588 - S589
  • [39] CYP2C19*2 polymorphism in Polish peptic ulcer patients
    Aleksandra Sałagacka-Kubiak
    Marta Żebrowska-Nawrocka
    Agnieszka Jeleń
    Marek Mirowski
    Ewa Balcerczak
    Pharmacological Reports, 2019, 71 : 272 - 275
  • [40] CYP2C19*2 polymorphism in Polish peptic ulcer patients
    Salagacka-Kubiak, Aleksandra
    Zebrowska-Nawrocka, Marta
    Jelen, Agnieszka
    Mirowski, Marek
    Balcerczak, Ewa
    PHARMACOLOGICAL REPORTS, 2019, 71 (02) : 272 - 275
12345